Determination of Serum Homocysteine and Hypersensitive C-reactive Protein and Their Correlation with Premature Coronary Heart Disease

  • Songsen Li Department of Cardiology, Luoyang Center Hospital Affiliated to Zhengzhou University, Luoyang, China
  • Guangjie Pan Department of Cardiology, Luoyang Center Hospital Affiliated to Zhengzhou University, Luoyang, China
  • Huili Chen Department of Cardiology, Luoyang Center Hospital Affiliated to Zhengzhou University, Luoyang, China
  • Xiaohua Niu Department of Cardiology, Luoyang Center Hospital Affiliated to Zhengzhou University, Luoyang, China

Abstract

Background: This study aims to investigate the correlation between premature coronary heart disease (pCHD) and both serum homocysteine (Hcy) and hypersensitive C-reactive protein (hs-CRP).

Methods: A total of 170 patients with pCHD were enrolled in this study from June 2014 to April 2016 (including 52 patients with stable angina pectoris [SAP], 70 patients with unstable angina pectoris [UAP], and 48 patients with acute myocardial infarction [AMI]), together with 105 healthy controls (CON) selected at the same period, to observe the changes of Hcy and hs-CRP in CHD patients and those with different types of CHD.

Results: The levels of serum Hcy and hs-CRP in group pCHD were significantly higher than in group CON (P < .05). The levels of Hcy and hs-CRP in group AMI were significantly higher than in group UAP and group SAP (P < .05). The changes of serum Hcy and hs-CRP were significantly higher in patients with multi-vascular lesions and dual-vascular lesions than in those with single-vascular lesion (P < .05).

Conclusion: The levels of serum Hcy and hs-CRP in CHD patients are positively correlated with the severity of CHD, which increase with the increase of lesion count. The combined detection of Hcy and hs-CRP can initially reflect the severity of coronary artery, thus better guiding treatment and predicting prognosis.

References

Buckley DI, Fu R, Freeman M, et al. 2009. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 151:483-95.

Devaraj S, Singh U, Jialal I. 2009. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 55:229-38.

Feng L, Nian S, Zhang S, et al. 2016. The associations between serum biomarkers and stenosis of the coronary arteries. Oncotarget 7:39231-40.

Gong X, Zou X, Liu L, et al. 2013. Prognostic value of inflammatory mediators in 1-year outcome of acute ischemic stroke with middle cerebral artery stenosis. Mediators Inflamm 2013:850714.

Hernández-Díaz Y, Tovilla-Zárate CA, Juárez-Rojop I, et al. 2015. The role of gene variants of the inflammatory markers CRP and TNF-α in cardiovascular heart disease: systematic review and meta-analysis. Int J Clin Exp Med 8:11958-84.

Holven KB, Aukrust P, Retterstol K, et al. 2006. Increased levels of C-reactive protein and interleukin-6 in hyperhomocysteinemic subjects. Scand J Clin Lab Invest 66:45-54.

Li T, Chen Y, Li J, et al. 2015. Serum homocysteine concentration is significantly associated with inflammatory/immune factors. PLoS One 10:e0138099.

Libby P, Okamoto Y, Rocha VZ, et al. 2010. Inflammation in atherosclerosis: transition from theory to practice. Circ J 74:213-20.

Liu C, Yang Y, Peng D, et al. 2015. Hyperhomocysteinemia as a metabolic disorder parameter is independently associated with the severity of coronary heart disease. Saudi Med J 36:839-46.

Liuzzo G, Biasucci LM, Gallimore JR, et al. 1994. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-24.

Men X, Li J, Zhang B, et al. 2013. Homocysteine and C-reactive protein associated with progression and prognosis of intracranial branch atheromatous disease. PLoS One 8:e73030.

Pang X, Liu J, Zhao J, et al. 2014. Homocysteine induces the expression of C-reactive protein via NMDAr-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells. Atherosclerosis 236:73-81.

Pang X, Liu J, Li Y, et al. 2015. Emodin inhibits homocysteine-induced C-reactive protein generation in vascular smooth muscle cells by regulating PPARγ expression and ROS-ERK1/2/p38 signal pathway. PLoS One 10:e0131295.

Pietilä KO, Harmoinen AP, Jokiniitty J, et al. 1996. Serum C-reactive protein concentration in acute myocardial infarction and its relationship to mortality during 24 months of follow-up in patients under thrombolytic treatment. Eur Heart J 17:1345-9.

Plank F, Burghard P, Friedrich G, et al. 2016. Quantitative coronary CT angiography: absolute lumen sizing rather than % stenosis predicts hemodynamically relevant stenosis. Eur Radiol 26:3781-9.

Schroecksnadel K, Grammer TB, Boehm BO, et al. 2010. Total homocysteine in patients with angiographic coronary artery disease correlates with inflammation markers. Thromb Haemost 103:926-35.

Steed MM, Tyagi SC. 2011. Mechanisms of cardiovascular remodeling in hyperhomocysteinemia. Antioxid Redox Signal 15:1927-43.

Strang F, Schunkert H. 2014. C-reactive protein and coronary heart disease: all said—is not it? Mediators Inflamm 2014:757123.

Suleiman M, Aronson D, Reisner SA, et al. 2003. Admission C-reactive protein levels and 30-day mortality in patients with acute myocardial infarction. Am J Med 115:695-701.

Suleiman M, Khatib R, Agmon Y, et al. 2006. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein. J Am Coll Cardiol 47:962-8.

Weber C, Noels H. 2011. Atherosclerosis: current pathogenesis and therapeutic options. Nat Med 17:1410-22.

Published
2019-05-22
Section
Articles